3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
63
Carcinoma, Intraductal, Noninfiltrating
8
Breast Carcinoma In Situ
6
Neoplasms
4
Breast Neoplasms, Male
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Infertility
2
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pinealoma
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Medulloblastoma
1
Inflammatory Breast Neoplasms
1
Hypogonadism
1
Hyperglycemia
1
Hot Flashes
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
Tamoxifen
×
1 year
×
Clear all
No trials found.